ValenTx Competitors and Similar CompaniesClear all
ValenTx's competitors and similar companies include Cell MedX and Tandem Diabetes Care.
 ValenTx ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. |  Cell MedX Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. |  Tandem Diabetes Care Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. | |
Founding Date | Founding Date 2002 | Founding Date 2014 | Founding Date 2006 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Maple Grove, US HQ | Locations Carson City, US HQ | Locations San Diego, US HQ Markham, CA Schiphol, NL |
Employees | Employees 10 | Employees 150% decrease | Employees 2,65010% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.5 m | Valuation ($) 2.2 b |
Financial | |||
Net income | Net income N/A | Net income ($566.3k) (FY, 2025) | Net income ($204.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 38.1m | Total funding raised N/A | Total funding raised $ 401.5m |
For sources of this data, please see the company profile
View Company Profiles
Cell MedX
HQ
Carson City, US
Employees
1↓ 50% decrease
Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
View companyTandem Diabetes Care
HQ
San Diego, US
Employees
2,650↑ 10% increase
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes.
View company